Treating hypertriglyceridemia.
Yavasoglu
Irfan
I
Kadikoylu
Gurhan
G
Bolaman
Zahit
Z
D000328:Adult; D002995:Clofibric Acid / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000097:blood; D004032:Diet; D015444:Exercise; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015228:Hypertriglyceridemia / Q000145:classification / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D009525:Niacin / Q000627:therapeutic use; D010195:Pancreatitis / Q000097:blood; D010956:Plasmapheresis; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood; D015431:Weight Loss
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D007328:Insulin; D014280:Triglycerides; D009525:Niacin; D002995:Clofibric Acid; D006493:Heparin